Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,968 | -48,916 | -145,226 | -104,311 | -68,986 |
| Depreciation Amortization | 3,002 | 1,491 | 4,673 | 3,113 | 1,785 |
| Accounts receivable | -84 | -61 | 130 | 130 | 130 |
| Accounts payable and accrued liabilities | 792 | 2,332 | -705 | -724 | 216 |
| Other Working Capital | -2,032 | 1,416 | 3,162 | 181 | 2,135 |
| Other Operating Activity | 12,047 | 3,794 | 22,665 | 16,910 | 10,857 |
| Operating Cash Flow | $-82,243 | $-39,944 | $-115,301 | $-84,701 | $-53,863 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -340 | -23 | -686 | -419 | -439 |
| Investing Cash Flow | $-340 | $-23 | $-686 | $-419 | $-439 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | 128,863 | 98,871 | 98,871 |
| Common Stock Issued | 1,210 | 356 | 2,757 | 1,071 | 565 |
| Other Financing Activity | 0 | 0 | 126,931 | -50 | -50 |
| Financing Cash Flow | $1,210 | $356 | $258,551 | $99,892 | $99,386 |
| Beginning Cash Position | 273,865 | 273,865 | 131,301 | 131,301 | 131,301 |
| End Cash Position | 192,492 | 234,254 | 273,865 | 146,073 | 176,385 |
| Net Cash Flow | $-81,373 | $-39,611 | $142,564 | $14,772 | $45,084 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,243 | -39,944 | -115,301 | -84,701 | -53,863 |
| Capital Expenditure | -340 | -23 | -686 | -419 | -439 |
| Free Cash Flow | -82,583 | -39,967 | -115,987 | -85,120 | -54,302 |